Process Research and Development of Antibodies as Countermeasures for C. botulinum
Abstract
This final report describes the design and construction of a CGMP facility for yeast and bacteria on the first floor and basement of Othmer Hall, the home for the University of Nebraska-Lincoln Biological Process Development Facility. Total cost for construction was $11,165,740, with the University of Nebraska-Lincoln providing $5,179,226 (46%) of the funding, USAMRMC providing $4,958,049 (45%), and JVAP providing $1,028,465 (9 %). This final report also describes the expression, purification and media optimization of a monoclonal antibody against serotype A botulinum neurotoxin.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2009
- Accession Number
- ADA503782
Entities
People
- Michael Meagher
Organizations
- University of Nebraska–Lincoln